LTRN - Lantern Pharma Inc
2.7
-0.060 -2.222%
Share volume: 31,301
Last Updated: 03-11-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$2.76
-0.06
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-07-2024 | 03-27-2025 | 05-15-2025 | 11-12-2025 | |
| Assets | |||||||
| Total Assets | 39.734 M | 35.587 M | 30.293 M | 25.572 M | 21.096 M | 13.627 M | |
| Current Assets | 39.471 M | 35.292 M | 29.921 M | 25.248 M | 20.823 M | 13.461 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 20.000 M | 20.286 M | 19.951 M | 16.502 M | 13.344 M | 3.973 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 18.358 M | 12.977 M | 8.103 M | 7.511 M | 6.378 M | 8.389 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 50.283 K | 50.292 K | 48.931 K | 47.440 K | 44.025 K | 35.977 K | |
| Other Assets | 213.080 K | 245.060 K | 323.373 K | 276.723 K | 228.934 K | 129.828 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 39.734 M | 35.587 M | 30.293 M | 25.572 M | 21.096 M | 13.627 M | |
| Total liabilities | 3.969 M | 4.655 M | 3.695 M | 4.384 M | 4.320 M | 4.040 M | |
| Total current liabilities | 3.953 M | 4.601 M | 3.601 M | 4.331 M | 4.286 M | 4.040 M | |
| Accounts Payable | 3.775 M | 4.437 M | 3.404 M | 4.140 M | 4.125 M | 3.946 M | |
| Other liabilities | 0.000 | 54.694 K | 0.000 | 52.843 K | 33.416 K | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 54.694 K | 0.000 | 52.843 K | 33.416 K | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 35.765 M | 30.931 M | 26.598 M | 21.188 M | 16.776 M | 9.587 M | |
| Common stock | 96.449 M | 96.583 M | 96.774 M | 97.059 M | 97.207 M | 98.617 M | |
| Retained earnings | -60.685 M | -65.645 M | -70.150 M | -76.026 M | -80.562 M | -89.071 M |